
Sintx Technologies, Inc. (NASDAQ:SINT – Free Report) – Stock analysts at HC Wainwright reduced their Q2 2026 earnings per share estimates for shares of Sintx Technologies in a research report issued on Wednesday, May 20th. HC Wainwright analyst B. Folkes now forecasts that the company will earn ($0.81) per share for the quarter, down from their prior estimate of ($0.78). HC Wainwright currently has a “Buy” rating and a $10.00 target price on the stock. The consensus estimate for Sintx Technologies’ current full-year earnings is ($2.16) per share. HC Wainwright also issued estimates for Sintx Technologies’ Q3 2026 earnings at ($0.43) EPS, Q4 2026 earnings at ($0.50) EPS, FY2026 earnings at ($2.27) EPS, FY2027 earnings at ($1.50) EPS, FY2028 earnings at ($0.74) EPS, FY2029 earnings at $1.37 EPS and FY2030 earnings at $2.06 EPS.
Sintx Technologies (NASDAQ:SINT – Get Free Report) last issued its earnings results on Friday, May 15th. The company reported ($0.70) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.66) by ($0.04). The company had revenue of $0.38 million during the quarter, compared to analyst estimates of $0.30 million. Sintx Technologies had a negative return on equity of 366.49% and a negative net margin of 1,058.60%.
Read Our Latest Research Report on SINT
Sintx Technologies Stock Up 4.1%
NASDAQ:SINT opened at $2.30 on Friday. Sintx Technologies has a 1-year low of $1.99 and a 1-year high of $6.78. The firm has a market capitalization of $9.94 million, a price-to-earnings ratio of -0.45 and a beta of 0.61. The stock has a fifty day simple moving average of $2.51 and a 200 day simple moving average of $3.10.
Institutional Inflows and Outflows
An institutional investor recently raised its position in Sintx Technologies stock. Geode Capital Management LLC increased its holdings in Sintx Technologies, Inc. (NASDAQ:SINT – Free Report) by 33.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 15,339 shares of the company’s stock after acquiring an additional 3,848 shares during the period. Geode Capital Management LLC owned about 0.56% of Sintx Technologies worth $49,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 18.38% of the company’s stock.
About Sintx Technologies
Sintx Technologies, Inc (NASDAQ: SINT) is a medical materials company specializing in the development and manufacture of silicon nitride-based biomaterials for surgical and implantable medical devices. Its proprietary silicon nitride ceramic combines mechanical strength, biocompatibility and intrinsic antimicrobial properties, positioning it as an alternative to traditional metal and polymer implant materials. Sintx’s primary focus is on applications in spinal fusion, trauma fixation and dental implantology, where device performance and long-term biological response are critical.
The company’s core product offerings include silicon nitride powders for advanced implant fabrication and finished implantable components designed for interbody spinal fusion cages, spinal fixation hardware and trauma plates and screws.
See Also
- Five stocks we like better than Sintx Technologies
- Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending
- As Small-Cap Outperformance Continues, These 2 ETFs Provide Exposure
- Silicon Shake-Up: The AI Trade Is Moving Beyond NVIDIA
- The Silver Lining of Last Week’s Hims & Hers Earnings Miss
Receive News & Ratings for Sintx Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sintx Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
